![Fred van Leuven](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fred van Leuven
Corporate Officer/Principal at
Katholieke Universiteit Leuven
Profile
Fred van Leuven is the founder of AC Immune SA, founded in 2003, and reMYND NV, founded in 2002.
Dr. van Leuven currently holds the position of Professor at Katholieke Universiteit Leuven.
Dr. van Leuven earned a doctorate degree from Ghent University in 1976 and a graduate degree from Ghent University in 1970.
Fred van Leuven active positions
| Companies | Position | Start |
|---|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Fred van Leuven
| Companies | Position | End |
|---|---|---|
| AC IMMUNE SA | Founder | - |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Founder | - |
Training of Fred van Leuven
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Commercial Services |
- Stock Market
- Insiders
- Fred van Leuven
